Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
INR 34.65
(-1.08%)
INR 34.65
(-1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -60.73 Million INR | -8738.98% |
| 2022 | 703 Thousand INR | 138.67% |
| 2021 | -1.81 Million INR | 65.47% |
| 2020 | -5.26 Million INR | -944.76% |
| 2019 | -503.87 Thousand INR | -740.17% |
| 2018 | -59.97 Thousand INR | 85.32% |
| 2017 | -408.66 Thousand INR | -223.6% |
| 2016 | -126.28 Thousand INR | -722.84% |
| 2015 | 20.27 Thousand INR | 108.43% |
| 2014 | -240.49 Thousand INR | 20.88% |
| 2013 | -303.95 Thousand INR | 2.37% |
| 2012 | -311.33 Thousand INR | 49.22% |
| 2011 | -613.08 Thousand INR | 19.19% |
| 2010 | -758.66 Thousand INR | 22.89% |
| 2009 | -983.81 Thousand INR | -96.1% |
| 2008 | -501.68 Thousand INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | -60.73 Million INR | -8738.98% |
| 2023 Q3 | - INR | 100.0% |
| 2023 Q2 | -758 Thousand INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | -60.73 Million INR | 0.0% |
| 2022 Q4 | 703 Thousand INR | 0.0% |
| 2022 FY | 703 Thousand INR | 138.67% |
| 2022 Q1 | - INR | 100.0% |
| 2022 Q2 | -24.26 Million INR | 0.0% |
| 2022 Q3 | - INR | 100.0% |
| 2021 Q1 | - INR | 100.0% |
| 2021 Q3 | - INR | 100.0% |
| 2021 Q2 | -270 Thousand INR | 0.0% |
| 2021 FY | -1.81 Million INR | 65.47% |
| 2021 Q4 | -1.81 Million INR | 0.0% |
| 2020 FY | -5.26 Million INR | -944.76% |
| 2020 Q4 | -5.26 Million INR | 0.0% |
| 2020 Q2 | -6.78 Million INR | 0.0% |
| 2019 FY | -503.87 Thousand INR | -740.17% |
| 2019 Q2 | - INR | 0.0% |
| 2019 Q4 | -503.87 Thousand INR | 0.0% |
| 2018 FY | -59.97 Thousand INR | 85.32% |
| 2018 Q2 | -260 Thousand INR | 0.0% |
| 2018 Q4 | -59.97 Thousand INR | 0.0% |
| 2017 Q2 | -1.04 Million INR | 0.0% |
| 2017 Q4 | -408.66 Thousand INR | 0.0% |
| 2017 FY | -408.66 Thousand INR | -223.6% |
| 2016 FY | -126.28 Thousand INR | -722.84% |
| 2016 Q4 | -126.28 Thousand INR | 0.0% |
| 2016 Q2 | -5.62 Million INR | 0.0% |
| 2015 FY | 20.27 Thousand INR | 108.43% |
| 2015 Q2 | 720 Thousand INR | 0.0% |
| 2015 Q4 | 20.27 Thousand INR | 0.0% |
| 2014 Q4 | -240.49 Thousand INR | 0.0% |
| 2014 Q2 | -610 Thousand INR | 0.0% |
| 2014 FY | -240.49 Thousand INR | 20.88% |
| 2013 Q4 | -303.95 Thousand INR | 67.46% |
| 2013 Q3 | -934 Thousand INR | 53.97% |
| 2013 FY | -303.95 Thousand INR | 2.37% |
| 2013 Q2 | -2.02 Million INR | 0.0% |
| 2012 Q3 | -922 Thousand INR | 0.0% |
| 2012 Q4 | -311.33 Thousand INR | 66.23% |
| 2012 FY | -311.33 Thousand INR | 49.22% |
| 2011 FY | -613.08 Thousand INR | 19.19% |
| 2011 Q4 | -613.08 Thousand INR | 0.0% |
| 2010 FY | -758.66 Thousand INR | 22.89% |
| 2009 FY | -983.81 Thousand INR | -96.1% |
| 2008 FY | -501.68 Thousand INR | 0.0% |
| 2008 Q4 | -501.68 Thousand INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 109.051% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 152.243% |
| Bacil Pharma Limited | 569 Thousand INR | 10773.462% |
| Beryl Drugs Limited | 48.7 Million INR | 224.686% |
| Cian Healthcare Limited | 544.97 Million INR | 111.144% |
| Colinz Laboratories Limited | -64.3 Million INR | 5.553% |
| Concord Drugs Limited | 164.48 Million INR | 136.922% |
| Deccan Health Care Limited | -7.07 Million INR | -758.282% |
| Gennex Laboratories Limited | -552.54 Million INR | 89.009% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 260.82% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | -26.267% |
| Kerala Ayurveda Limited | 447.82 Million INR | 113.561% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 106.589% |
| Mercury Laboratories Limited | -26.72 Million INR | -127.214% |
| Panchsheel Organics Limited | -157.82 Million INR | 61.518% |
| Parmax Pharma Limited | 51.8 Million INR | 217.221% |
| Parnax Lab Limited | 787.61 Million INR | 107.711% |
| Patidar Buildcon Limited | 25.12 Million INR | 341.71% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 262.873% |
| Phaarmasia Limited | -4.89 Million INR | -1140.188% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -431.339% |
| Sastasundar Ventures Limited | -297.24 Million INR | 79.569% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -36.097% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -3.663% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 105.801% |
| Sunil Healthcare Limited | 625.4 Million INR | 109.711% |
| Syschem (India) Limited | 3.53 Million INR | 1819.479% |
| Trident Lifeline Limited | 117.56 Million INR | 151.66% |
| Transchem Limited | -3.16 Million INR | -1820.076% |
| Tyche Industries Limited | -788.94 Million INR | 92.302% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 257.235% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 20.25% |
| Zenith Healthcare Limited | -25.45 Million INR | -138.567% |
| Zenotech Laboratories Limited | -196.85 Million INR | 69.149% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | 340.872% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 114.067% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -902.509% |
| MedPlus Health Services Limited | 8.67 Billion INR | 100.7% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 29.34% |
| Smruthi Organics Limited | 111.28 Million INR | 154.571% |
| Trimurthi Limited | -1.17 Million INR | -5054.643% |
| Zenlabs Ethica Limited | 139.54 Million INR | 143.521% |
| Makers Laboratories Limited | 172.59 Million INR | 135.188% |
| Lactose (India) Limited | 373.97 Million INR | 116.24% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 108.81% |
| Roopa Industries Limited | 216.01 Million INR | 128.115% |
| PANJON LTD. | -12.8 Million INR | -374.172% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 551.707% |
| Anuh Pharma Limited | -69.8 Million INR | 13.0% |
| Crestchem Limited | -1.45 Million INR | -4088.414% |
| PRAVEG LIMITED | -434.98 Million INR | 86.038% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 105.817% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 11.035% |
| Norris Medicines Limited | 214.86 Million INR | 128.266% |
| Denis Chem Lab Limited | -236.28 Million INR | 74.297% |
| Veerhealth Care Limited | -2.38 Million INR | -2446.415% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 92.331% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 110.63% |
| Godavari Drugs Limited | 530.02 Million INR | 111.458% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -552.331% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 145.974% |
| Vivanza Biosciences Limited | 50.02 Million INR | 221.401% |
| Medi-Caps Limited | -3.21 Million INR | -1789.608% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 34.794% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 130.087% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | -12.709% |
| Bharat Parenterals Limited | 1.48 Billion INR | 104.08% |
| BDH Industries Limited | -164.47 Million INR | 63.074% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 177.165% |
| Coral Laboratories Limited | -612.82 Million INR | 90.09% |
| Evoq Remedies Limited | 41.14 Million INR | 247.594% |
| Trinity League India Limited | -12 Thousand INR | -506000.0% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 104.353% |
| Natural Capsules Limited | 956.68 Million INR | 106.348% |
| Auro Laboratories Limited | 252.51 Million INR | 124.051% |